Skip to main content

GX Marijuana Life Sciences Index ETF(HMMJ-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Horizons Marijuana Life Sciences ETF up on Friday (HMMJ)

Automated Summaries - The Globe and Mail - Fri Apr 26, 4:02PM CDT

Horizons Marijuana Life Sciences ETF opened trading today at $10.17 and closed at $10.27. prices ranged from a low of $10.17 to a high of $10.49.

Shares gained 0.79% from the previous day's close of $10.19.

Today across North America, the TSX Composite closed 0.38% at 21969.24, the S&P 500 closed -0.46% at 5048.42, the Dow Jones Industrial Average closed -0.98% at 38085.80 and the Nasdaq Composite closed -0.64% at 15611.76.

Horizons Marijuana Life Sciences ETF has listed on the Toronto Stock Exchange (TSX) under the ticker HMMJ.

Trading volume was 3,176 on 23 total trades. On average, Horizons Marijuana Life Sciences ETF has traded 3,312 shares in the last five days and 12,294 year-to-date.

The TSX overall saw 3,324 price advancers against 1,856 declines and 124 unchanged.

During the prior 52 weeks, HMMJ.TO has traded as high as $11.91 (April 04,2024) and low as $8.07 (October 27,2023). Moreover, the shares have advanced 8.68% in 52 weeks, while in 2024, they have advanced 10.55%.

Following today's trading, Horizons Marijuana Life Sciences ETF has a market capitalization of $0.00 on a float of 0 shares outstanding. Its annual EPS is $None.

Horizons Marijuana Life Sciences ETF is a None company headquartered in, None.

The Horizons Marijuana Life Sciences Index ETF seeks to replicate, to the extent possible, the performance of the North American Marijuana Index, net of expenses. The Index is designed to provide exposure to the performance of a basket of North American publicly listed life sciences companies with significant business activities in the marijuana industry..

Based on 0.00 analysts, Horizons Marijuana Life Sciences ETF gets an average recommendation of "Strong Sell" according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe